Projects per year
Fingerprint
Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 15 Finished
-
Defining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML
Konopleva, M. (PI)
5/20/22 → 3/31/23
Project: Research project
-
Inhibition of Bcl-xL by Targeted Degradation
Zheng, G. (PI), Zhou, D. (CoPI) & Konopleva, M. (CoPI)
4/1/20 → 3/31/25
Project: Research project
-
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
Konopleva, M. (PI), Spencer, D. D. H. (CoPI), Konopleva, M. M. Y. (CoPI) & Welch, J. S. (CoPI)
6/17/19 → 5/31/25
Project: Research project
-
Targeting mitochondrial complex I in acute lymphoblastic leukemia
Konopleva, M. (PI) & Konopleva, M. M. Y. (CoPI)
6/14/19 → 5/31/25
Project: Research project
-
Career Enhancement Program
Konopleva, M. (PI), Konopleva, M. M. Y. (PI) & Kantarjian, H. (PI)
9/1/18 → 8/31/23
Project: Research project
-
Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant period
Cooper, D. L., Verceles, J. A., Kheradmand, T., Paroder, M., Lombardo, A., de Castro, A., Browne, R., Konopleva, M., Moavero, B., Goldfinger, M., Mantzaris, I., Kornblum, N., Sica, R. A., Shastri, A., Shapiro, L. C., Peeke, S. Z., Gupta, R., Gritsman, K., Feldman, E. J. & Verma, A., Oct 2025, In: Transfusion. 65, 10, p. 1978-1981 4 p.Research output: Contribution to journal › Article › peer-review
-
A germline FLT3 variant in aplastic anemia
Amaeshi, L. C., Sofianidi, A. A., Shastri, A., Goldfinger, M., Konopleva, M., Verma, A. K., Chaitowitz, M. & Mantzaris, I., Dec 2025, In: Biomarker Research. 13, 1, 4.Research output: Contribution to journal › Letter › peer-review
Open Access -
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models
Kannan, S., Li, Y., Baran, N., Yang, X., Ghotbaldini, S., Tatarata, Q. Z., Yoshimura, S., Li, Z., Hsiao, Y. C., Balachander, S., Andersen, C. L., Cidado, J., Yu, J., Jain, N., Yang, J. J. & Konopleva, M., Feb 11 2025, In: Blood Advances. 9, 3, p. 473-487 15 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Senapati, J., Konopleva, M., Issa, G. C., Jabbour, E., Kadia, T., DiNardo, C., Borthakur, G., Pemmaraju, N., Short, N. J., Yilmaz, M., Deshmukh, I., Alvarez, J., Loghavi, S., Tang, G., Abbas, H. A., Andreeff, M., Bhalla, K., Midde, N. M., Said, N. & Noyalis, A. & 7 others, , Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 108.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia
Goulart, H., Jabbour, E., Short, N. J., Kadia, T. M., Pemmaraju, N., Takahashi, K., Ravandi, F., Konopleva, M. & Jain, N., Nov 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 11, p. 800-807 8 p.Research output: Contribution to journal › Article › peer-review